Showing results (671-680 of 2,168) with videos related to
Sort By:
Pageof 217
Journal of Biopharmaceutical Statistics|April 2, 2010
Statistical characterization of QT prolongationRobert Schall, Arne RingJournal of Biopharmaceutical Statistics|April 2, 2010
Sample size calculations for crossover thorough QT studies: satisfaction of regulatory threshold and assay sensitivitySuraj P Anand, Sharon C Murray, Gary G KochJournal of Biopharmaceutical Statistics|April 2, 2010
Multiple comparisons of repeated measured response: issues of assessment of prolongation of QT interval in thorough QT trialsYi Tsong, Jinglin ZhongJournal of Biopharmaceutical Statistics|April 2, 2010
A comparison of several methods for analyzing data from thorough QT studiesHong Tian, Wenqian Qiao, Jaya NatarajanJournal of Biopharmaceutical Statistics|April 23, 2009
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experienceElisabeth I Heath, Patricia M LoRusso, S Percy Ivy, et al.Journal of Biopharmaceutical Statistics|April 23, 2009
Continual reassessment method vs. traditional empirically based design: modifications motivated by Phase I trials in pediatric oncology by the Pediatric Brain Tumor ConsortiumArzu Onar, Mehmet Kocak, James M BoyettJournal of Biopharmaceutical Statistics|September 10, 2016
Fisher, Neyman, and Bayes at FDADonald B RubinJournal of Biopharmaceutical Statistics|May 26, 2017
Maximum Likelihood Estimation of Titer via a Power Family of Four-Parameter Logistic ModelHongmei Yang, Jeanne Holden-Wiltse, David J Topham, et al.Journal of Biopharmaceutical Statistics|November 11, 2005
Decision-theoretic views on simultaneous testing of superiority and noninferiorityTatsuki Koyama, Peter H WestfallJournal of Biopharmaceutical Statistics|November 11, 2005
Sample size calculation for simulation-based multiple-testing proceduresHeejung Bang, Sin-Ho Jung, Stephen L GeorgePageof 217